H.R. 4623 · 119th Congress (2025–2027)
Plain Prescription Prices Act
This bill requires the Centers for Medicare & Medicaid Services to issue a rule requiring direct-to-consumer television advertisements for prescription drugs that are covered by Medicare or Medicaid to include a textual statement of the drug's list price.
Show official title
To require direct-to-consumer advertisements for prescription drugs and biological products to include truthful and not misleading pricing information.
Referred to committee
Latest actionReferred to committee
This bill’s path
This is H.R. 4623’s recorded path, not a universal congressional workflow.
How bills become lawAll actionsIntroduced
Passed House
Passed Senate
Sent to President
Signed into law
- Sponsor
- Rep. Nikema Williams (D-GA-5)
- Cosponsors
4 cosponsors
3 original · 1 later
- Rep. Don Bacon (R-NE-2)· Original · Jul 22, 2025
- Rep. Angie Craig (D-MN-2)· Original · Jul 22, 2025
- Rep. Bryan Steil (R-WI-1)· Original · Jul 22, 2025
- Rep. Tom Barrett (R-MI-7)· Later · Nov 20, 2025
- Policy area
- Health
On this page
Timeline
i
In chronological order. Major procedural acts are shown in full. Committee work and ordinary amendments fold in place where they happened, so they do not jump the sequence or stretch the timeline.
Introduced in House
Document: Introduced in House
Sources
- Congress.gov actionIntro-H
- Library of Congress
- Latest
Referred to committee
Referred to the Committee on Energy and Commerce, and in addition to the Committee on Ways and Means, for a period to be subsequently determined by the Speaker, in each case for consideration of such provisions as fall within the jurisdiction of the committee concerned.
Sources
- Congress.gov action
- House floor actions
Committees
Text & titles
i
Each distinct name Congress.gov recorded, once. Official, short, display, and popular titles stay distinct when the wording differs. The same wording is not repeated for every text version.
| Version | Date | Links |
|---|---|---|
| Introduced in House |
Titles (2)
Plain Prescription Prices Act
Display title, Short title · Introduced in House
To require direct-to-consumer advertisements for prescription drugs and biological products to include truthful and not misleading pricing information.
Official title · Introduced in House